These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33331120)

  • 1. Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?
    Lui DTW; Tan KCB
    J Diabetes Investig; 2021 Apr; 12(4):479-481. PubMed ID: 33331120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
    Scheen AJ; Paquot N
    Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".
    Al-Salameh A; Wiernsperger N; Cariou B; Lalau JD
    Diabetes Obes Metab; 2022 Sep; 24(9):1888-1893. PubMed ID: 35545864
    [No Abstract]   [Full Text] [Related]  

  • 5. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
    Scheen AJ
    Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
    Almirall J; Bricullé M; Gonzalez-Clemente JM
    Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to "Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study".
    Kumar S; Raja R
    Acta Diabetol; 2022 Jun; 59(6):869-870. PubMed ID: 35246718
    [No Abstract]   [Full Text] [Related]  

  • 9. Pre-diabetes and COVID-19, could we be missing the silent killer?
    Sosibo AM; Khathi A
    Exp Biol Med (Maywood); 2021 Feb; 246(4):369-370. PubMed ID: 33215530
    [No Abstract]   [Full Text] [Related]  

  • 10. A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis.
    Hotta N
    J Diabetes Investig; 2019 Jul; 10(4):906-908. PubMed ID: 31152685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
    Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
    Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acidosis in medical ICU - the role of diabetes mellitus and metformin.
    Hloch O; Charvat J; Masopust J; Havlin J
    Neuro Endocrinol Lett; 2012; 33(8):792-5. PubMed ID: 23391971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.
    Richy FF; Sabidó-Espin M; Guedes S; Corvino FA; Gottwald-Hostalek U
    Diabetes Care; 2014 Aug; 37(8):2291-5. PubMed ID: 24879835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.
    Lalau JD; Kajbaf F; Protti A; Christensen MM; De Broe ME; Wiernsperger N
    Diabetes Obes Metab; 2017 Nov; 19(11):1502-1512. PubMed ID: 28417525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
    Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.
    Yang W; Sun X; Zhang J; Zhang K
    Diabetes Res Clin Pract; 2021 Aug; 178():108977. PubMed ID: 34302912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and the incidence of cancer in patients with diabetes: a nested case-control study.
    Wang SY; Chuang CS; Muo CH; Tu ST; Lin MC; Sung FC; Kao CH
    Diabetes Care; 2013 Sep; 36(9):e155-6. PubMed ID: 23970729
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.
    Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
    Arch Intern Med; 2003 Nov; 163(21):2594-602. PubMed ID: 14638559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metformin and kidneys].
    Smahelová A
    Vnitr Lek; 2008 May; 54(5):535-40. PubMed ID: 18630642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus: Complex interplay between metformin, AKI and lactic acidosis.
    Rhee CM; Kalantar-Zadeh K
    Nat Rev Nephrol; 2017 Sep; 13(9):521-522. PubMed ID: 28736433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.